Cancer Enzyme Capsules for Colon Cancer

Colon cancer affects one in 20 women and one in 17 men. The risk of developing colon cancer increases with age. More than half of colorectal cancer patients are older than 70 years. Among the under 55-year-olds the rate is only about 10 percent. The mean age of onset is 76 years for women and 72 years for men, and is therefore comparatively high.

With colon cancer, women have a relative chance of survival of 63 percent within five years, while it is only one percent less for men, at 62 percent.

The colon cancer enzyme No. 6 slows down the growth and spread of cancer cells in the organism.

Cancer cells use various strategies to bypass the body's natural immune defenses. To wander to other parts of the body undetected, they camouflage themselves with a cover made of an endogenous substance. Colon cancer enzyme NO. 6, however, can recognize these cells and destroy them. This effectively prevents metastases.

Cancer cells can also form structures that the immune system classifies as harmful and destroys them. As a result, living cancer cells remain undetected and can multiply freely. This deception is also undermined by the colon cancer enzyme No. 6, which splits these camouflaging structures.

We recommend taking one capsule twice a day.